These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31132336)

  • 1. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
    Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
    Park JS; Sue CM
    Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal.
    de Tezanos Pinto F; Adamo HP
    Neurochem Int; 2018 Jan; 112():108-113. PubMed ID: 29169913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity.
    Rinaldi DE; Corradi GR; Cuesta LM; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta; 2015 Aug; 1848(8):1646-55. PubMed ID: 25912790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice.
    Sato S; Koike M; Funayama M; Ezaki J; Fukuda T; Ueno T; Uchiyama Y; Hattori N
    Am J Pathol; 2016 Dec; 186(12):3074-3082. PubMed ID: 27770614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
    Yang X; Xu Y
    Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-associated ATP13A2/PARK9 functions as a lysosomal H
    Fujii T; Nagamori S; Wiriyasermkul P; Zheng S; Yago A; Shimizu T; Tabuchi Y; Okumura T; Fujii T; Takeshima H; Sakai H
    Nat Commun; 2023 Apr; 14(1):2174. PubMed ID: 37080960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis.
    Schmutz I; Jagannathan V; Bartenschlager F; Stein VM; Gruber AD; Leeb T; Katz ML
    Mol Genet Metab; 2019 May; 127(1):95-106. PubMed ID: 30956123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.
    Schultheis PJ; Fleming SM; Clippinger AK; Lewis J; Tsunemi T; Giasson B; Dickson DW; Mazzulli JR; Bardgett ME; Haik KL; Ekhator O; Chava AK; Howard J; Gannon M; Hoffman E; Chen Y; Prasad V; Linn SC; Tamargo RJ; Westbroek W; Sidransky E; Krainc D; Shull GE
    Hum Mol Genet; 2013 May; 22(10):2067-82. PubMed ID: 23393156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake.
    De La Hera DP; Corradi GR; Adamo HP; De Tezanos Pinto F
    Biochem J; 2013 Feb; 450(1):47-53. PubMed ID: 23205587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
    Bras J; Verloes A; Schneider SA; Mole SE; Guerreiro RJ
    Hum Mol Genet; 2012 Jun; 21(12):2646-50. PubMed ID: 22388936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lipid switch unlocks Parkinson's disease-associated ATP13A2.
    Holemans T; Sørensen DM; van Veen S; Martin S; Hermans D; Kemmer GC; Van den Haute C; Baekelandt V; Günther Pomorski T; Agostinis P; Wuytack F; Palmgren M; Eggermont J; Vangheluwe P
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9040-5. PubMed ID: 26134396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial loss of ATP13A2 causes selective gliosis independent of robust lipofuscinosis.
    Rayaprolu S; Seven YB; Howard J; Duffy C; Altshuler M; Moloney C; Giasson BI; Lewis J
    Mol Cell Neurosci; 2018 Oct; 92():17-26. PubMed ID: 29859891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.
    Tan J; Zhang T; Jiang L; Chi J; Hu D; Pan Q; Wang D; Zhang Z
    J Biol Chem; 2011 Aug; 286(34):29654-62. PubMed ID: 21724849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.